期刊
NUCLEAR MEDICINE AND BIOLOGY
卷 29, 期 5, 页码 599-606出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/S0969-8051(02)00322-0
关键词
PET; yttrium-86; imaging; radionuclide production and purification; monoclonal antibody
A simple and rapid procedure was developed for purification of cyclotron produced Y-86 via the Sr-86(p.n) Y-86 reaction. A commercially available Sr(II) selective resin was used to separate Y-86 from the cyclotron irradiated Sr(II) target with a recovery of the enriched Sr(II) target while yielding a 75-80% recovery of Y-86 suitable for radiolabeling either proteins or peptides. To demonstrate the utility of this methodology, the anti-HER2 monoclonal antibody Herceptin(TM) was radiolabeled with the purified Y-86 and compared to In-111 labeled Herceptin(TM). The biodistribution study demonstrated that In-111-Herceptin(TM) while a suitable surrogate for Y-90 in the major organs. did not parallel the uptake of Y-86-Herceptin(TM) in the bone, and thus may not accurately predict the level of Y-90 accumulation in the bone for clinical RIT applications. This result exemplifies the requirement of employing appropriate matched pair isotopes, for imaging and therapy to insure that dosimetry considerations may be addressed accurately. Published by Elsevier Science Inc. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据